Nektar Therapeutics (NKTR +6.7%) gets a lift after saying it will present positive...

|About: Nektar Therapeutics (NKTR)|By:, SA News Editor

Nektar Therapeutics (NKTR +6.7%) gets a lift after saying it will present positive proof-of-concept data from its first Phase 1 clinical trial of NKTR-181 at the American Academy of Pain Management's 22nd Annual Clinical Meeting.